Sai Ravi Pingali Selected Research

Sai Ravi Pingali Research Topics

6	Neoplasms (Cancer) 01/2022 - 01/2018
4	Infections 01/2020 - 01/2018
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 08/2015
3	Multiple Myeloma 01/2022 - 11/2020
3	Hodgkin Disease (Hodgkin's Disease) 01/2018 - 07/2014
2	Leukemia 12/2023 - 03/2021
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2022 - 01/2020
2	Cytokine Release Syndrome 03/2021 - 10/2020
2	Cardiotoxicity 03/2021 - 01/2019
2	COVID-19 03/2021 - 10/2020
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2020 - 01/2018
1	Lymphoma (Lymphomas) 01/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2021
1	Death (Near-Death Experience) 03/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2021
1	Pneumonia (Pneumonitis) 03/2021
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Critical Illness (Critically Ill) 10/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020
1	Polycythemia Vera 01/2020
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2020
1	Tuberculosis (Tuberculoses) 01/2020
1	Disease Progression 01/2020
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2019
1	Histiocytic Sarcoma 01/2019
1	Eosinophilia 01/2019
1	Viremia 01/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Meningoencephalitis 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Second Primary Neoplasms (Neoplasms, Second) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 08/2015

2	Monoclonal AntibodiesIBA 12/2023 - 10/2020
2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2021
2	Proteasome InhibitorsIBA 01/2022 - 01/2021
2	Brentuximab VedotinIBA 01/2022 - 01/2018
2	NivolumabIBA 01/2020 - 01/2018
2	pembrolizumabIBA 01/2020 - 01/2018
2	IpilimumabIBA 01/2020 - 01/2018
2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2020
1	AntibodiesIBA 12/2023
1	CholesterolIBA 12/2023
1	Cell Surface ReceptorsIBA 12/2023
1	Cytidine DeaminaseIBA 10/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	IceIBA 01/2022
1	Ifosfamide FDA LinkGeneric 01/2022
1	romidepsin (FK228)FDA Link 01/2022
1	carfilzomibIBA 01/2022
1	Chimeric Antigen ReceptorsIBA 03/2021
1	Oxygen (Dioxygen)IBA 03/2021
1	EnzymesIBA 03/2021
1	CytokinesIBA 10/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2020
1	tocilizumab (atlizumab)FDA Link 10/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	ruxolitinibIBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2019
1	Muramidase (Lysozyme)IBA 01/2019
1	pegaspargase (Oncaspar)FDA Link 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2018
1	ibrutinibIBA 01/2018
1	B7-H1 AntigenIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Calcineurin InhibitorsIBA 08/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2015

6	Therapeutics 01/2023 - 07/2014
4	Drug Therapy (Chemotherapy) 12/2023 - 01/2019
3	Radiotherapy 01/2023 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 03/2021 - 10/2020
2	Transplantation 07/2017 - 08/2015
1	Length of Stay 03/2021
1	Biological Therapy 11/2020
1	Craniotomy 01/2019
1	Cell Transplantation 01/2018
1	Stem Cell Transplantation 01/2018
1	Conformal Radiotherapy 01/2018
1	Autologous Transplantation 07/2017